HowShorted

How shorted is IGC Pharma, Inc.?

More shorted than 6% of the 2,877 ranked US companies

0.55%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
+0.16
5 reports (~10 weeks)
−0.62
Aggregate net short position time series for IGC Pharma, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 20260.55%+0.16
15 Jul 20260.39%−0.10
30 Jun 20260.49%−0.70
29 May 20261.19%−0.12
15 May 20261.31%+0.14
30 Apr 20261.17%+0.28
15 Apr 20260.89%+0.14
31 Mar 20260.75%+0.07
13 Mar 20260.68%−0.05
27 Feb 20260.73%+0.10
13 Feb 20260.63%−0.01
30 Jan 20260.64%+0.30
15 Jan 20260.34%−0.07
31 Dec 20250.41%−0.05
15 Dec 20250.46%+0.14
28 Nov 20250.32%+0.06
14 Nov 20250.26%−0.05
31 Oct 20250.31%−0.02
15 Oct 20250.33%−0.06
30 Sep 20250.39%−0.06
15 Sep 20250.45%−0.63
29 Aug 20251.08%−0.23
15 Aug 20251.31%−0.27
31 Jul 20251.58%–

Frequently asked questions

How shorted is IGC Pharma, Inc. right now?
0.55% of IGC Pharma, Inc.'s (IGC) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.